300 Frank W. Burr Blvd
Teaneck, NJ 07666
United States
To schedule an appointment, please call the CLEI Patient Coordinator at 201-692-9434.
Medical professionals: to refer a patient for PROSE treatment at the Cornea and Laser Eye Institute, please complete the referral form and fax it, with your last note to the attention of the PROSE Clinic at 201-692-9646.
Founded in 1995, the Cornea and Laser Eye Institute in Teaneck, New Jersey is dedicated to clinical care and research in cornea disease and refractive surgery. In 2002, the CLEI Center for Keratoconus was formally inaugurated, it is recognized worldwide and is a one of the nation’s only sub-specialty centers completely focused on treatment and research in keratoconus. The center’s contribution to keratoconus management has included the FDA approval of corneal collagen crosslinking in the US as well as many seminal papers on keratoconus treatment. Most recently the PROSE clinic at CLEI was founded to aid patients with severe corneal and ocular surface disease.
CLEI is directed by Peter S. Hersh, M.D., a graduate of Princeton University, Johns Hopkins Medical School, and Harvard Medical School’s ophthalmology residency and corneal surgery fellowship programs. He is joined by John D. Gelles, O.D., Steven A. Greenstein, M.D. and David S. Chu, M.D. All hold academic appointments at Rutgers New Jersey Medical School Department of Ophthalmology and Visual Science.
BostonSight PROSE Clinical Fellow
Dr. Gelles is the director of the specialty contact lens division of the Cornea and Laser Eye Institute-Hersh Vision Group and the CLEI Center for Keratoconus in Teaneck, NJ. He graduated from University of Oregon and received his optometry degree from Pennsylvania College of Optometry. He is a clinical assistant professor at Rutgers New Jersey Medical School and an adjunct clinical professor for State University of New York College of Optometry, Illinois College of Optometry and New England College of Optometry. He is a fellow of the Contact Lens Society of America, the Scleral Lens Society, the British Contact Lens Association, and the International Academy of Orthokeratology and Myopia Control. He is a board member of the Contact Lens Society of America, an executive board member of the International Keratoconus Academy, an advisory board member for the Gas Permeable Lens Institute and the education chair of the Intrepid Eye Society. His clinical work is dedicated exclusively to specialty contact lenses and co-management for keratoconus and other corneal disease, ocular surface disease, and post-surgical corneal conditions. He is a clinical investigator for multiple keratoconus and specialty contact lens related clinical trials at CLEI and has produced multiple journal articles with Dr. Hersh and Greenstein. He is invited regularly to lecture both nationally and internationally on specialty contact lenses and keratoconus at optometric and ophthalmologic meetings and is a frequent author in several professional publications.
Cornea and Refractive Surgery
Dr. Greenstein, graduated from New York University and received his medical degree from the Albert Einstein College of Medicine. He graduated with a special distinction in clinical research after completing a one-year pre-residency research fellowship concentrating on keratoconus and corneal cross-linking with Dr. Hersh. He completed an ophthalmology residency at Rutgers New Jersey Medical School and a cornea, refractive and external disease fellowship at Harvard Medical School. He is an assistant clinical professor at Rutgers New Jersey Medical School and an associate team ophthalmologist for the NY Jets. He specializes in keratoconus, corneal and vision correction surgery. His research interests include surgical treatment for keratoconus and novel techniques for corneal surgery. Dr. Greenstein is also involved in a number of clinical research studies designed to evaluate the safety and efficacy of new treatments and techniques for keratoconus and vision correction procedures. He has published a multitude of articles in prestigious medical journals, many of these papers are considered landmark papers out of the US on crosslinking. In addition to publications, he has presented at numerous scientific meetings on research related to keratoconus and has co-authored several book chapters with Dr. Hersh on corneal collagen crosslinking for keratoconus and corneal ectasia.
Cornea, Uveitis and Ocular Immunology
Dr. Chu received his bachelor’s degree from Bowdoin College. He is a graduate of New York University School of Medicine and completed his ophthalmology residency at New York Medical College. He then completed a fellowship in ocular inflammatory disease and uveitis at Harvard Medical School. He is an assistant professor at Rutgers New Jersey Medical School and an associate team ophthalmologist for the NY Jets. He specializes in corneal diseases and nationally recognized for his expertise in inflammatory and immunologic conditions. His research interests include corneal wound healing, surgical and non-surgical therapies for various ocular surface and inflammatory diseases. Dr. Chu is also involved in a number of clinical research studies designed to evaluate the safety and efficacy of new drugs and techniques in the treatment of corneal and ocular inflammatory disorders. Dr. Chu is a renowned leader in areas of uveitis, ocular immunology and cornea surgeries. He is a principal investigator in numerous research projects and clinical trials. He is the past president of the Foster Ocular Immunology Society and is a board member of the Ocular Immunology and Uveitis Foundation. Additionally, he is the medical director of Eversight Eye Bank and Eversight International.
Cornea and Refractive Surgery
Dr. Hersh graduated from Princeton University and received his medical degree from Johns Hopkins Medical School. He completed his ophthalmology residency and fellowship training in corneal surgery at Harvard Medical School. He remained on the full-time faculty at Harvard for several years. In 1995, he founded the Cornea and Laser Eye Institute – Hersh Vision Group, dedicated to clinical care and research in refractive and corneal surgery. He founded the CLEI Center for Keratoconus in 2002, a subspecialty center focused on treatment and research in keratoconus. He is a clinical professor and the director of the cornea and refractive surgery division at Rutgers New Jersey Medical School and a visiting research collaborator at Princeton University in the Department of Aerospace and Mechanical Engineering investigating new laser applications to eye surgery. He has served as a lead author, principal investigator and/or medical monitor for the FDA approval of landmark procedures and treatments related to keratoconus, corneal and refractive surgery. Most prominently, he was lead author of the clinical study that led to the FDA approval of laser eye surgery for the treatment of nearsightedness in the United States in 1995. More recently, Dr. Hersh served as medical monitor and was lead author of the two studies leading to U.S. FDA approvals of corneal collagen crosslinking (CXL) for keratoconus and corneal ectasia. He has published four textbooks, more than 100 research articles and multiple book chapters. He was elected to the American Ophthalmological Society and awarded the Senior Honor Award from the American Academy of Ophthalmology. He is also a Life Fellow of AAO. He has trained over a thousand eye surgeons in excimer laser refractive surgery techniques, and is past recipient of the Teacher of the Year award bestowed by the Harvard Medical School Department of Ophthalmology. As a result of his philanthropic work in a number of international projects to bring education and eye care to developing countries, he was awarded a Paul Harris Fellowship from Rotary International. Dr. Hersh has a longstanding interest in sports eye injuries and was co-author of the book Eye Trauma.
